ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy

计划入组 6 人 · 首次发布于 2025 年 10 月 20 日

A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)

计划入组 35 人 · 首次发布于 2023 年 8 月 8 日

Observational Study of Natural History of BAG3 Gene Mutation-Associated Dilated Cardiomyopathy in Chinese Adults

计划入组 10 人 · 首次发布于 2026 年 6 月 15 日

Dilated cardiomyopathy therapy (Maze Therapeutics)

LMNA gene therapy (LMNA-related dilated cardiomyopathy)

AAV-BAG3

Lexeo Therapeutics

United States

MiNK Therapeutics

United States

Mesoblast

United States

Solid Biosciences' SGT-212 Receives FDA IND Clearance for Friedreich's Ataxia Gene Therapy Trial

Affinia Therapeutics Partners with DCM Foundation to Advance BAG3 Dilated Cardiomyopathy Awareness and Genetic Testing

Affinia Therapeutics Advances AFTX-201 for BAG3 Dilated Cardiomyopathy